Dr Lalchandani Labs (BOM:541299) 3-Year Revenue Growth Rate : -6.00% (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs 3-Year Revenue Growth Rate?

Dr Lalchandani Labs's Revenue per Share for the six months ended in Sep. 2023 was ₹6.19.

During the past 12 months, Dr Lalchandani Labs's average Revenue per Share Growth Rate was -1.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -6.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Dr Lalchandani Labs was 51.90% per year. The lowest was -6.00% per year. And the median was 24.55% per year.

Competitive Comparison of Dr Lalchandani Labs's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Lalchandani Labs's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's 3-Year Revenue Growth Rate falls into.

Dr Lalchandani Labs 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Dr Lalchandani Labs (BOM:541299) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Dr Lalchandani Labs 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines